Less Ads, More Data, More Tools Register for FREE

UPDATE 1-Morocco reports its first case of UK coronavirus variant, bans more flights

Mon, 18th Jan 2021 23:04

(Adds new travel ban)

Rabat, Jan 18 (Reuters) - Morocco’s health ministry
confirmed on Monday its first imported case of the more
contagious variant of the novel coronavirus first discovered in
the UK.

The variant was detected in the northern port of Tangier in
a Moroccan national returning from Ireland via Marseille, the
ministry said in a statement.

On Monday, the foreign ministry said travellers from
Australia, Brazil, Ireland and New Zealand will not be allowed
into the country. Morocco has suspended flights coming from the
UK since late December in an effort to protect against further
spread of the virus.

Morocco has announced it plans to launch a free vaccination
campaign targeting 25 million people, or 80% of its population.

The country ordered 66 million vaccine doses from
AstraZeneca Plc and China’s Sinopharm. It has not yet
received any.

On Dec. 23, Morocco imposed a nationwide four-week curfew
from 9:00 pm to 6:00 am to contain virus.

On Monday, the country said it has recorded a total of
460,144 coronavirus infections including 7,977 deaths and 16,481
active cases.

Health experts have raised concerns over new highly
transmissible mutations of the virus first reported in the UK
and South Africa and now cropping up in several other countries.
A third new variant has since been reported in Brazil.
(Reporting by Ahmed Eljechtimi
Editing by Bill Berkrot)

Related Shares

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...

28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...

27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.